Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsCamson bio technologies

    Camson Bio Technologies

    Jump to

    • Camson Bio Tech Standalone March 2019 Net Sales at Rs 0.59 crore, up 215.46% Y-o-Y

    • Camson Bio Tech Standalone September 2018 Net Sales at Rs 1.52 crore, down 67.68% Y-o-Y

    • Camson Bio Tech consolidated Mar '15 sales at Rs 46.17 crore

      Camson Bio Technologies has reported a consolidated total income from operations of Rs 46.17 crore and a net loss of Rs 4.06 crore for the quarter ended Mar '15

    • Look at Camson Bio Technologies: Prakash Diwan

      Prakash Diwan, Director of Altamount Capital Management is of the view that one may look at Camson Bio Technologies with a target of Rs 180.

    • Here are some stock picks from Prakash Diwan

      Watch the interview of Prakash Diwan, Director of Altamount Capital Management with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his reading and outlook on market and specific stocks.

    • Unseasonal rains to stretch working cap cycle: Camson Bio

      In an interview with CNBC-TV18‘s Reema Tendulkar and Mangalam Maloo, Santosh Nair, CEO of Camson Bio Technologies, outlined the state of business.

    • Buy Camson Bio Tech; target of Rs 189: Karvy Stock Broking

      Brokerage house Karvy Stock Broking is bullish on Camson Bio Technologies and has recommended buy rating on the stock with a target price of Rs 189 in its research report dated April 06, 2015.

    • Demerger of seeds biz to take 2-3 months: Camson Bio Tech

      Both the businesses that is biocides and hybrid seeds are growing rapidly, so it was time to unlock value both for shareholders and focus on driving the businesses differently, saidSantosh Nair, CEO of Camson Bio Technologies.

    • Top buzzing midcap stocks to trade on March 13

      Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Adani Port, Aurobindo Pharma, DLF, Camson Bio, Finolex Industries, Natco Pharma and Inox Leisure.

    • Camson Bio Tech consolidated Dec '14 sales at Rs 63.51 crore

      Camson Bio Technologies has reported a consolidated total income from operations of Rs 63.51 crore and a net profit of Rs 1.75 crore for the quarter ended Dec '14

    • Buy DCB Bank, LIC Housing, Camson Bio Tech: Dharmesh Kant

      Dharmesh Kant of India Nivesh Securities recommends buying Camson Bio Technologies for a price target of Rs 175 and LIC Housing Finance for a price target of Rs 390.

    • Bull's Eye: Buy Ashok Leyland, DCB Bank, Lupin, LIC Housing

      Dharmesh Kant of India Nivesh Securities recommends buying DCB Bank for a target price of Rs 99 and LIC Housing Finance for a target price of Rs 390.

    • Buy Ahmednagar Forg, Canara Bank, Thomas Cook: Kant

      Dharmesh Kant of India Nivesh Securities recommends buying Thomas Cook (India) for a price target of Rs 175 and Camson Bio Technologies Limited for a price target of Rs 175.

    • Bull's Eye: Buy Canara Bank, SAIL, Ashok Leyland

      Dharmesh Kant of India Nivesh Securities recommends buying Ahmednagar Forgings for a target price of Rs 430 and Canara Bank for a target price of Rs 420.

    • Camson Bio Tech standalone Dec '13 sales at Rs 43.88 crore

      Camson Bio Technologies has reported a sales standalone turnover of Rs 43.88 crore and a net profit of Rs 2.42 crore for the quarter ended Dec '13

    • Camson Bio Tech standalone Sep '13 sales at Rs 31.92 crore

      Camson Bio Technologies has reported a sales standalone turnover of Rs 31.92 crore and a net profit of Rs 0.32 crore for the quarter ended Sep '13

    • Camson Bio Tech standalone Jun '13 sales at Rs 30.71 crore

      Camson Bio Technologies has reported a sales standalone turnover of Rs 30.71 crore and a net profit of Rs 2.37 crore for the quarter ended Jun '13

    • Camson Bio Tech standalone Dec '12 sales at Rs 39.11 crore

      Camson Bio Technologies has reported a sales standalone turnover of Rs 39.11 crore and a net profit of Rs 6.70 crore for the quarter ended Dec '12

    • Camson Bio Tech Sep '12 sales at Rs 17.10 crore

      Camson Bio Technologies has reported a sales turnover of Rs 17.10 crore and a net profit of Rs 1.70 crore for the quarter ended Sep '12

    • Camson Bio approves pref issue of 60 lakh warrants; stk up

      Camson Bio Technologies has approved preferential issue of 60 lakh warrants at the rate of Rs 70 to Promoters/investors, reports CNBC-TV18. At 09:28 hrs Camson Bio Technologies was quoting at Rs 59.95, up Rs 1.45, or 2.48%.

    • Camson Bio Tech Mar '12 sales at Rs 29.42 crore

      Camson Bio Technologies has reported a sales turnover of Rs 29.42 crore and a net profit of Rs 6.46 crore for the quarter ended Mar '12

    • Camson Bio Tech Mar '11 sales at Rs 23.06 crore

      Camson Bio Technologies has reported a sales turnover of Rs 23.06 crore and a net profit of Rs 6.18 crore for the quarter ended Mar '11

    • Camson Bio Tech Dec '10 sales at Rs 32.33 crore

      Camson Bio Technologies has reported a sales turnover of Rs 32.33 crore and a net profit of Rs 7.30 crore for the quarter ended Dec '10

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347